Above all, take safety seriously
View BPC-157 / KPV / TB-500 Blend The standard protocol involves 1.6 mg subcutaneous injections twice weekly for 12-16 weeks
According to FDA labeling and American Diabetes Association guidelines, GLP-1 receptor agonists are indicated for type 2 diabetes (as an adjunct to diet and exercise) and for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Beyond that distinction, general handling principles gentle introduction of bacteriostatic water, swirling rather than shaking, and prompt refrigerated storage apply the same way to blended vials as they do to single-peptide vials
The compound incorporates three non-standard structural features: an -aminoisobutyric acid (Aib) at the N-terminus bearing no stereocenter, a D-2-naphthylalanine (D-2-Nal) at position 3, and a D-phenylalanine at position 4
We can provide these in our office or for your convenience on-site